Omnicell Inc (OMCL)
46.48
-1.33
(-2.78%)
USD |
NASDAQ |
Nov 14, 16:00
46.48
0.00 (0.00%)
After-Hours: 20:00
Omnicell Enterprise Value: 2.204B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 2.204B |
| November 12, 2024 | 2.254B |
| November 11, 2024 | 2.253B |
| November 08, 2024 | 2.312B |
| November 07, 2024 | 2.419B |
| November 06, 2024 | 2.421B |
| November 05, 2024 | 2.296B |
| November 04, 2024 | 2.236B |
| November 01, 2024 | 2.244B |
| October 31, 2024 | 2.243B |
| October 30, 2024 | 2.447B |
| October 29, 2024 | 1.848B |
| October 28, 2024 | 1.860B |
| October 25, 2024 | 1.819B |
| October 24, 2024 | 1.807B |
| October 23, 2024 | 1.839B |
| October 22, 2024 | 1.893B |
| October 21, 2024 | 1.864B |
| October 18, 2024 | 1.893B |
| October 17, 2024 | 1.908B |
| October 16, 2024 | 1.961B |
| October 15, 2024 | 1.952B |
| October 14, 2024 | 1.969B |
| October 11, 2024 | 1.964B |
| October 10, 2024 | 1.940B |
| Date | Value |
|---|---|
| October 09, 2024 | 1.979B |
| October 08, 2024 | 1.983B |
| October 07, 2024 | 1.946B |
| October 04, 2024 | 1.953B |
| October 03, 2024 | 1.912B |
| October 02, 2024 | 1.949B |
| October 01, 2024 | 1.952B |
| September 30, 2024 | 2.009B |
| September 27, 2024 | 1.981B |
| September 26, 2024 | 1.949B |
| September 25, 2024 | 1.959B |
| September 24, 2024 | 1.977B |
| September 23, 2024 | 2.028B |
| September 20, 2024 | 2.054B |
| September 19, 2024 | 1.999B |
| September 18, 2024 | 1.969B |
| September 17, 2024 | 2.068B |
| September 16, 2024 | 2.066B |
| September 13, 2024 | 1.987B |
| September 12, 2024 | 1.972B |
| September 11, 2024 | 1.983B |
| September 10, 2024 | 1.992B |
| September 09, 2024 | 2.048B |
| September 06, 2024 | 2.085B |
| September 05, 2024 | 2.048B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.180B
Minimum
Jul 10 2024
8.103B
Maximum
Jan 03 2022
3.801B
Average
3.269B
Median
Enterprise Value Benchmarks
| 10x Genomics Inc | 1.408B |
| American Shared Hospital Services | 29.34M |
| Astrana Health Inc | 1.805B |
| Cryo-Cell International Inc | 82.53M |
| P3 Health Partners Inc | 299.28M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 8.63M |
| Revenue (Quarterly) | 282.42M |
| Total Expenses (Quarterly) | 275.86M |
| EPS Diluted (Quarterly) | 0.19 |
| Gross Profit Margin (Quarterly) | 43.29% |
| Profit Margin (Quarterly) | 3.06% |
| Earnings Yield | -0.84% |
| Normalized Earnings Yield | -0.8390 |